Goal and Learning Outcomes

Upon completion of this activity, participants should be able to:

  • Critically evaluate study results from recent trials of AD regarding treatment efficacy and safety
  • Describe how new trial data will affect/change the management of patients with AD


Andrew F. Alexis, MD, MPH

Department of Dermatology
Icahn School of Medicine at Mount Sinai
Director, Skin of Color Center
Mount Sinai West and Mount Sinai Morningside
New York, New York

Jonathan Silverberg, MD

Associate Professor, Dermatology
Director of Clinical Research
Director of Patch Testing

George Washington University School of Medicine and Health Sciences
Washington, DC

Accreditation Information

This course is being provided by a Relias LLC strategic partner.  Consumption of this course will take place on the partners site and courses provided in this manner are not accredited by Relias LLC.